Cardiac Surgery 2020 Reviewed

Abstract

In 2020, nearly 30,000 published references appeared in the PubMed for the search term “cardiac surgery.” While SARS-CoV-2 affected the number of surgical procedures, it did not affect outcomes reporting. Using the PRISMA approach, we selected relevant publications and prepared a results-oriented summary. We reviewed primarily the fields of coronary and conventional valve surgery and their overlap with interventional alternatives. The coronary field started with a discussion on trial data value and their interpretation. Registry comparisons of coronary artery bypass surgery (CABG) and percutaneous coronary intervention confirmed outcomes for severe coronary artery disease and advanced comorbidities with CABG. Multiple arterial grafting was best. In aortic valve surgery, meta-analyses of randomized trials report that transcatheter aortic valve implantation may provide a short-term advantage but long-term survival may be better with classic aortic valve replacement (AVR). Minimally invasive AVR and decellularized homografts emerged as hopeful techniques. In mitral and tricuspid valve surgery, excellent perioperative and long-term outcomes were presented for structural mitral regurgitation. For both, coronary and valve surgery, outcomes are strongly dependent on surgeon expertise. Kidney disease increases perioperative risk, but does not limit the surgical treatment effect. Finally, a cursory look is thrown on aortic, transplant, and assist-device surgery with a glimpse into the current stand of xenotransplantation. As in recent years, this article summarizes publications perceived as important by us. It does not expect to be complete and cannot be free of individual interpretation. We aimed to provide up-to-date information for decision-making and patient information.

Keyword

coronary artery bypass surgery - CABG - aortic valve - mitral valve surgery - tricuspid valve - transplantation - heart

Publication History

Received: 12 February 2021

Accepted: 01 March 2021

Article published online:
29 July 2021

• References

• 1 Gregson J, Stone GW, Ben-Yehuda O. et al. Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization. J Am Coll Cardiol 2020; 76: 1609-1621
• 2 Stone GW, Kappetein AP, Sabik JF. et al. Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. N Engl J Med 2019; 381: 1820-1830
• 3 Hara H, Serruys PW, Takahashi K. et al. Impact of Peri-Procedural Myocardial Infarction on Outcomes After Revascularization. J Am Coll Cardiol 2020; 76: 1622-1639
• 4 Ahmad Y, Howard JP, Arnold AD. et al. Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 2020; 41: 3228-3235
• 5 Gaudino M, Hameed I, Farkouh ME. et al. Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis. JAMA Intern Med 2020; 180: 1638-1646
• 6 Brophy JM. Bayesian Interpretation of the EXCEL Trial and Other Randomized Clinical Trials of Left Main Coronary Artery Revascularization. JAMA Intern Med 2020; 180: 986-992
• 7 Takahashi K, Serruys PW, Fuster V. et al. Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation. Lancet 2020; 396: 1399-1412
• 8 Gaudino M, Hameed I, Rahouma M. et al. Characteristics of Contemporary Randomized Clinical Trials and Their Association With the Trial Funding Source in Invasive Cardiovascular Interventions. JAMA Intern Med 2020; 180: 993-1001
• 9 Gaudino M, Kappetein AP, Di Franco A. et al. Randomized Trials in Cardiac Surgery: JACC Review Topic of the Week. J Am Coll Cardiol 2020; 75: 1593-1604
• 10 Falk V, Friede T. Noninferiority trials: What's clinically (ir)relevant?. J Thorac Cardiovasc Surg 2021; 161: 2119-2123
• 11 Gaudino M, Bagiella E, Chang HL, Kurlansky P. Randomized trials, observational studies, and the illusive search for the source of truth. J Thorac Cardiovasc Surg 2020; DOI: 10.1016/j.jtcvs.2020.10.120.
• 12 Robich MP, Leavitt BJ, Ryan Jr. TJ. et al. Comparative effectiveness of revascularization strategies for early coronary artery disease: A multicenter analysis. J Thorac Cardiovasc Surg 2020; DOI: 10.1016/j.jtcvs.2020.03.164.
• 13 Gaudino M, Hameed I, Khan FM. et al. Treatment strategies in ischaemic left ventricular dysfunction: a network meta-analysis. Eur J Cardiothorac Surg 2020; DOI: 10.1093/ejcts/ezaa319.
• 14 Doenst T, Haddad H, Stebbins A. et al. Renal function and coronary bypass surgery in patients with ischemic heart failure. J Thorac Cardiovasc Surg 2020; DOI: 10.1016/j.jtcvs.2020.02.136.
• 15 Doulamis IP, Tzani A, Tzoumas A, Iliopoulos DC, Kampaktsis PN, Briasoulis A. Percutaneous Coronary Intervention With Drug Eluting Stents Versus Coronary Artery Bypass Graft Surgery in Patients With Advanced Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Semin Thorac Cardiovasc Surg 2020; DOI: 10.1053/j.semtcvs.2020.11.005.
• 16 Doenst T, Haverich A, Serruys P. et al. PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week. J Am Coll Cardiol 2019; 73: 964-976
• 17 Doenst T, Sigusch H. Surgical collateralization: The hidden mechanism for improving prognosis in chronic coronary syndromes. J Thorac Cardiovasc Surg 2020; DOI: 10.1016/j.jtcvs.2020.10.121.
• 18 Maron DJ, Hochman JS, Reynolds HR. et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med 2020; 382: 1395-1407
• 19 Miller RJH, Bonow RO, Gransar H. et al. Percutaneous or surgical revascularization is associated with survival benefit in stable coronary artery disease. Eur Heart J Cardiovasc Imaging 2020; 21: 961-970
• 20 Hachamovitch R, Rozanski A, Shaw LJ. et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J 2011; 32: 1012-1024
• 21 Neumann FJ, Sousa-Uva M, Ahlsson A. et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40: 87-165
• 22 Holm NR, Makikallio T, Lindsay MM. et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. Lancet 2020; 395: 191-199
• 23 Sun LY, Gaudino M, Chen RJ, Bader Eddeen A, Ruel M. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting. JAMA Cardiol 2020; 5: 631-641
• 24 Tam DY, Dharma C, Rocha R. et al. Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease. J Am Coll Cardiol 2020; 76: 1153-1164
• 25 Han JJ, Bojko MM, Duda MM. et al. Association Among Surgeon Experience, Patient Risk, and Outcomes in Coronary Artery Bypass Grafting. Ann Thorac Surg 2021; 111: 86-93
• 26 Taggart DP, Gaudino MF, Gerry S. et al. Ten-year outcomes after off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial. J Thorac Cardiovasc Surg 2020; DOI: 10.1016/j.jtcvs.2020.02.035.
• 27 Gaudino M, Rahouma M, Abouarab A. et al. Radial artery versus saphenous vein as the second conduit for coronary artery bypass surgery: A meta-analysis. J Thorac Cardiovasc Surg 2019; 157: 1819-1825 e1810
• 28 Doenst T, Diab M, Sponholz C, Bauer M, Farber G. The Opportunities and Limitations of Minimally Invasive Cardiac Surgery. Dtsch Arztebl Int 2017; 114: 777-784
• 29 Davierwala PM, Verevkin A, Sgouropoulou S. et al. Minimally invasive coronary bypass surgery with bilateral internal thoracic arteries: Early outcomes and angiographic patency. J Thorac Cardiovasc Surg 2020; DOI: 10.1016/j.jtcvs.2019.12.136.
• 30 Diab M, Farber G, Sponholz C. et al. Coronary Artery Bypass Grafting using Bilateral Internal Thoracic Arteries through a Left-Sided Minithoracotomy: A Single-Center Starting Experience. Thorac Cardiovasc Surg 2019; 67: 437-443
• 31 Indja B, Woldendorp K, Black D, Bannon PG, Wilson MK, Vallely MP. Minimally invasive surgical approaches to left main and left anterior descending coronary artery revascularization are superior compared to first- and second-generation drug-eluting stents: a network meta-analysis. Eur J Cardiothorac Surg 2020; 57: 18-27
• 32 Writing Committee M. Otto CM, Nishimura RA. et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021; 77: 450-500
• 33 Barili F, Freemantle N, Pilozzi Casado A. et al. Mortality in trials on transcatheter aortic valve implantation versus surgical aortic valve replacement: a pooled meta-analysis of Kaplan-Meier-derived individual patient data. Eur J Cardiothorac Surg 2020; 58: 221-229
• 34 Celik M, Milojevic MM, Durko AP, Oei FBS, Bogers A, Mahtab EAF. Mortality in low-risk patients with aortic stenosis undergoing transcatheter or surgical aortic valve replacement: a reconstructed individual patient data meta-analysis. Interact Cardiovasc Thorac Surg 2020; 31: 587-594
• 35 Mack M, Leon MB. Two-year Clinical And Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial. . ACC; 29.03.2020.2020;
• 36 Makkar RR, Thourani VH, Mack MJ. et al. Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. N Engl J Med 2020; 382: 799-809
• 37 Farber G, Bleiziffer S, Doenst T. et al. Transcatheter or surgical aortic valve implantation in chronic dialysis patients: a German Aortic Valve Registry analysis. Clin Res Cardiol 2021; 110: 357-367
• 38 Pibarot P, Salaun E, Dahou A. et al. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial. Circulation 2020; 141: 1527-1537
• 39 Doenst T. Durability of tissue valves: Only time will tell?. J Thorac Cardiovasc Surg 2017; 154: 1243-1244
• 40 De Backer O, Dangas GD, Jilaihawi H. et al. Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement. N Engl J Med 2020; 382: 130-139
• 41 Laakso T, Laine M, Moriyama N. et al. Impact of paravalvular regurgitation on the mid-term outcome after transcatheter and surgical aortic valve replacement. Eur J Cardiothorac Surg 2020; 58: 1145-1152
• 42 Patel PM, Chiou E, Cao Y. et al. Isolated Redo-Aortic Valve Replacement versus Valve-in-Valve Transcatheter Valve Replacement. Ann Thorac Surg 2020; DOI: 10.1016/j.athoracsur.2020.08.048.
• 43 Deharo P, Bisson A, Herbert J. et al. Transcatheter Valve-in-Valve Aortic Valve Replacement as an Alternative to Surgical Re-Replacement. J Am Coll Cardiol 2020; 76: 489-499
• 44 Petrescu I, Egbe AC, Ionescu F. et al. Long-Term Outcomes of Anticoagulation for Bioprosthetic Valve Thrombosis. J Am Coll Cardiol 2020; 75: 857-866
• 45 Schneider U, Hofmann C, Schope J. et al. Long-term Results of Differentiated Anatomic Reconstruction of Bicuspid Aortic Valves. JAMA Cardiol 2020; 5: 1366-1373
• 46 Horke A, Tudorache I, Laufer G. et al. Early results from a prospective, single-arm European trial on decellularized allografts for aortic valve replacement: the ARISE study and ARISE Registry data. Eur J Cardiothorac Surg 2020; 58: 1045-1053
• 47 Bohbot Y, Candellier A, Diouf M. et al. Severe Aortic Stenosis and Chronic Kidney Disease: Outcomes and Impact of Aortic Valve Replacement. J Am Heart Assoc 2020; 9: e017190
• 48 Vollema EM, Prihadi EA, Ng ACT. et al. Prognostic Implications of Renal Dysfunction in Patients With Aortic Stenosis. Am J Cardiol 2020; 125: 1108-1114
• 49 Paparella D, Malvindi PG, Santarpino G. et al. Full sternotomy and minimal access approaches for surgical aortic valve replacement: a multicentre propensity-matched study. Eur J Cardiothorac Surg 2020; 57: 709-716
• 50 Ghoreishi M, Thourani VH, Badhwar V. et al. Less-Invasive Aortic Valve Replacement: Trends and Outcomes From The Society of Thoracic Surgeons Database. Ann Thorac Surg 2021; 111: 1216-1223
• 51 Wiedemann D, Laufer G, Coti I. et al. Anterior Right Thoracotomy for Rapid Deployment Aortic Valve Replacement. Ann Thorac Surg 2020; DOI: 10.1016/j.athoracsur.2020.09.023.
• 52 Tkebuchava S, Farber G, Sponholz C. et al. Minimally-invasive parasternal aortic valve replacement-A slow learning curve towards improved outcomes. J Card Surg 2020; 35: 544-548
• 53 Mack MJ, Leon MB, Thourani VH. et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med 2019; 380: 1695-1705
• 54 Desai A, Thomas JD, Bonow RO. et al. Asymptomatic degenerative mitral regurgitation repair: Validating guidelines for early intervention. J Thorac Cardiovasc Surg 2021; 161: 981-994 e985
• 55 Watt TMF, Brescia AA, Murray SL. et al. Degenerative Mitral Valve Repair Restores Life Expectancy. Ann Thorac Surg 2020; 109: 794-801
• 56 Pfannmueller B, Misfeld M, Verevkin A. et al. Loop neochord versus leaflet resection techniques for minimally invasive mitral valve repair: long-term results. Eur J Cardiothorac Surg 2021; 59: 180-186
• 57 Brescia AA, Watt TMF, Rosenbloom LM. et al. Anterior versus posterior leaflet mitral valve repair: A propensity-matched analysis. J Thorac Cardiovasc Surg 2020; DOI: 10.1016/j.jtcvs.2019.11.148.
• 58 Chikwe J, Toyoda N, Anyanwu AC. et al. Relation of Mitral Valve Surgery Volume to Repair Rate, Durability, and Survival. J Am Coll Cardiol 2017; DOI: 10.1016/j.jacc.2017.02.026.
• 59 Badhwar V, Vemulapalli S, Mack MA. et al. Volume-Outcome Association of Mitral Valve Surgery in the United States. JAMA Cardiol 2020; 5: 1092-1101
• 60 Dziadzko V, Clavel MA, Dziadzko M. et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet 2018; 391: 960-969
• 61 Yanagawa B, Lee J, Ouzounian M. et al. Mitral valve prosthesis choice in patients <70 years: A systematic review and meta-analysis of 20 219 patients. J Card Surg 2020; 35: 818-825
• 62 Javadikasgari H, Chemtob RA, Gillinov AM. et al. Outcomes of mitral valve re-replacement for bioprosthetic structural valve deterioration. J Thorac Cardiovasc Surg 2020; DOI: 10.1016/j.jtcvs.2020.08.067.
• 63 Dreyfus J, Flagiello M, Bazire B. et al. Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes. Eur Heart J 2020; 41: 4304-4317
• 64 Hirji S, Yazdchi F, Kiehm S. et al. Outcomes After Tricuspid Valve Repair With Ring Versus Suture Bicuspidization Annuloplasty. Ann Thorac Surg 2020; 110: 821-828
• 65 Peugnet F, Bohbot Y, Chadha G. et al. Improvement of the Prognosis Assessment of Severe Tricuspid Regurgitation by the Use of a Five-Grade Classification of Severity. Am J Cardiol 2020; 132: 119-125
• 66 Bothe W, Doenst T. Ring-Noose-String Technique Allows Adjustable Papillary Muscle Repositioning During Minimally Invasive Mitral Valve Repair in Patients with Functional/Ischemic Mitral Regurgitation. Thorac Cardiovasc Surg 2016; 64: 447-449
• 67 Doenst T, Faerber G. A new technique for tricuspid valve repair addressing the subvalvular apparatus in functional TR. EACTS. 2020
• 68 Czerny M, Pacini D, Aboyans V. et al. Current options and recommendations for the use of thoracic endovascular aortic repair in acute and chronic thoracic aortic disease: an expert consensus document of the European Society for Cardiology (ESC) Working Group of Cardiovascular Surgery, the ESC Working Group on Aorta and Peripheral Vascular Diseases, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2021; 59: 65-73
• 69 Shi F, Wang Z. Acute Aortic Dissection Surgery: Hybrid Debranching Versus Total Arch Replacement. J Cardiothorac Vasc Anesth 2020; 34: 1487-1493
• 70 Yan D, Shi H, Qin J. et al. Outcomes of emergency in situ laser fenestration-assisted thoracic endovascular aortic repair in patients with acute Stanford type A aortic dissection unfit for open surgery. J Vasc Surg 2020; 71: 1472-1479 e1471
• 71 Czerny M, Siepe M, Beyersdorf F. et al. Prediction of mortality rate in acute type A dissection: the German Registry for Acute Type A Aortic Dissection score. Eur J Cardiothorac Surg 2020; 58: 700-706
• 72 Goldstein DJ, Naka Y, Horstmanshof D. et al. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial. JAMA Cardiol 2020; 5: 411-419
• 73 Lala A, Rowland JC, Ferket BS. et al. Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure. JAMA Cardiol 2020; 5: 652-659
• 74 Yalcin YC, Muslem R, Veen KM. et al. Impact of preoperative liver dysfunction on outcomes in patients with left ventricular assist devices. Eur J Cardiothorac Surg 2020; 57: 920-928
• 75 Reichart B, Langin M, Radan J. et al. Pig-to-non-human primate heart transplantation: The final step toward clinical xenotransplantation?. J Heart Lung Transplant 2020; 39: 751-757
• 76 Buxton BF, Hayward PA, Raman J. et al. Long-Term Results of the RAPCO Trials. Circulation 2020; 142: 1330-1338
• 77 Gaudino M, Benedetto U, Fremes S. et al. Association of Radial Artery Graft vs Saphenous Vein Graft With Long-term Cardiovascular Outcomes Among Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis. JAMA 2020; 324: 179-187
• 78 Obed D, Fleissner F, Martens A. et al. Total Arterial Revascularization with Radial Artery and Internal Thoracic Artery T-Grafts Is Associated with Superior Long-Term Survival in Patients Undergoing Coronary Artery Bypass Grafting. Ann Thorac Cardiovasc Surg 2020; 26: 30-39
• 79 Pevni D, Ziv-Baran T, Kramer A, Farkash A, Ben-Gal Y. Is the Use of BITA vs SITA Grafting Safe and Beneficial in Octogenarians?. Ann Thorac Surg 2021; 111: 1998-2003
• 80 Rocha RV, Tam DY, Karkhanis R. et al. Long-term Outcomes Associated With Total Arterial Revascularization vs Non-Total Arterial Revascularization. JAMA Cardiol 2020; 5: 507-514
• 81 Royse AG, Bellomo R, Royse CF. et al. Radial Artery vs Bilateral Mammary Composite Y Coronary Artery Grafting: 15-Year Outcomes. Ann Thorac Surg 2021; 111: 1945-1953
• 82 Taggart DP, Gaudino MF, Gerry S. et al. Effect of total arterial grafting in the Arterial Revascularization Trial. J Thorac Cardiovasc Surg 2020; DOI: 10.1016/j.jtcvs.2020.03.013.
• 83 Gaudino M, Samadashvili Z, Hameed I, Chikwe J, Girardi LN, Hannan EL. Differences in Long-term Outcomes After Coronary Artery Bypass Grafting Using Single vs Multiple Arterial Grafts and the Association With Sex. JAMA Cardiol 2020; DOI: 10.1001/jamacardio.2020.6585.